🔗 Share this article TikTok Influencers Driving Parallel Trade for Unlicensed Slimming Medication An underground economy for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations. Experimental Drug Gaining Traction Online The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed fat-burning effects. Viewers are urged to message these accounts directly for supplier links, while also receiving discount codes. Active Trade on Social Networks Separately, a robust trade exists on messaging services, where groups with numerous of participants share “before and after” images, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before redirecting customers to WhatsApp for transactions. Learning About The Experimental Drug This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic. Healthcare Experts Voice Concerns However, physicians and chemists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could result in individuals injecting products of uncertain source. Some experts said the demand for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro. Legal Status and Implementation Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012. Several content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or prison. Platform Response and Content Elimination Based on the social media company, the service has removed problematic content and banned related keywords and search suggestions. The company stated it was dedicated to maintaining the platform safe and investing in enhancing compliance measures. Digital Marketplace Operations Investigations also found communities with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up groups with numerous of users, filled with photos of slimming results, glowing testimonials and detailed guides for mixing or injecting at residence. After minutes of entering one community, a vendor shared WhatsApp details, where most purchases occur. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about weight, medical conditions or past usage. Product Information and Costs Within these communities, messages show black plastic packages with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.” Buyers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20 milligrams. When asked how long a injector should last, sellers give contradictory responses ranging from a several days to “depends on your body”. Platform Oversight and Safety Actions A spokesperson for Telegram said it regularly moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”. Medical Professional Cautions “People are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these digital products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service. Dr Crystal Wyllie of an online medical service linked the surge in demand to current price rises for authorized slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said. Her team has already seen individuals injured by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.” Manufacturer Position A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose users to possibly significant medical dangers”.